U.S. FDA Issues Complete Response Letter for Baricitinib
Go back to U.S. FDA Issues Complete Response Letter for Baricitinib| Incyte Genomics, Inc. (NASDAQ: INCY) | Delayed: 107.39 -0.44 (0.41%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $107.83 | 52 Week High | $118.49 | |||
| Open | $108.15 | 52 Week Low | $55.00 | |||
| Day High | $108.37 | P/E | N/A | |||
| Day Low | $106.56 | EPS | $-0.56 | |||
| Volume | 53,893 | |||||
| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1153.47 -7.48 (0.64%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1160.95 | 52 Week High | $88.16 | |||
| Open | $1165.00 | 52 Week Low | $67.88 | |||
| Day High | $1169.99 | P/E | 267.01 | |||
| Day Low | $1150.00 | EPS | $4.32 | |||
| Volume | 165,885 | |||||
